Books > Medicine > Clinical & internal medicine > Hepatology
|
Buy Now
Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease, Volume 15-3 (Hardcover)
Loot Price: R1,663
Discovery Miles 16 630
|
|
Hepatitis C Direct Acting Antivirals: The New Standard of Care, An Issue of Clinics in Liver Disease, Volume 15-3 (Hardcover)
Series: The Clinics: Internal Medicine
Expected to ship within 10 - 15 working days
|
Hepatitis C Virus is a quickly evolving area within hepatology
owing to new medical therapies. This issue, guest edited by Dr.
Fred Poordad, includes the most current clinical information and
treatment therapies. Expert authors have written review articles
devoted to the following medical therapies: Boceprevir, Telaprevir,
Protease Inhibitors in Development, NS5B Nucleoside and
Non-Nucleoside Inhibitors. Review articles also address important
patients like na?ve- and non-responders and relapsers, the HIV
co-infected patient, and the Genotype 1 and non-Genotype 1 patient.
General
Imprint: |
WB Saunders
|
Country of origin: |
United Kingdom |
Series: |
The Clinics: Internal Medicine |
Release date: |
December 2011 |
First published: |
August 2011 |
Authors: |
Fred Poordad
|
Dimensions: |
239 x 163 x 18mm (L x W x T) |
Format: |
Hardcover
|
ISBN-13: |
978-1-4557-1107-9 |
Categories: |
Books >
Medicine >
Clinical & internal medicine >
Hepatology
Promotions
|
LSN: |
1-4557-1107-1 |
Barcode: |
9781455711079 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.